Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of glycyrrhizic acid pretreatment on talinolol pharmacokinetics in healthy men
ChiCTR-RRC-10000999Phase 4Completed
- Sponsor
- The Second Xiangya Hospital
- Start
- Sep 2009
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of glycyrrhizin and talinolol (2 arms), sponsored by The Second Xiangya Hospital. Primary endpoint: Serum concentration of talinolol. Started Sep 2009; status: completed.
02
Drugs
glycyrrhizintalinolol
Beyond the preview
Go deeper on ChiCTR-RRC-10000999.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-RRC-10000999.